Eli Lilly unexpectedly lowered its full-year 2024 guidance. The miss appears to stem from a lack of the typical December ...

Websites selling compounded versions of popular weight-loss drugs from Novo Nordisk and Eli Lilly to U.S. consumers often do ...

A Bucks County woman is speaking out after her insurance company decided to no longer cover weight loss drugs.

A recent study reveals many websites selling compounded versions of weight-loss drugs do not inform users of risks, often ...

Zyn nicotine pouches loved by young people for their appetite-suppressing effects have officially been approved in the US.

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Current laws and regulations are not enough to protect Americans from the risks of compounded versions of popular weight loss ...

In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...

Some people are microdosing certain weight loss drugs in an attempt to reap some of the drugs' benefits with fewer of their side effects. But doctors specializing in weight loss say that ...

Pharmaceutical giants Eli Lilly and Novo Nordisk, makers of Zepbound and Wegovy, respectively, have filed lawsuits against medical spas, weight-loss clinics, and compounding pharmacies they accuse of ...

The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, ...

People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.